Polivy (polatuzumab vedotin)

Diffuse large B-cell lymphoma not otherwise specified (DLBCL NOS), relapsed or refractory, in adult patients who are not eligible for autologous stem cell transplant & have received at least one prior therapy (In combination with bendamustine & rituximab)